Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstar Plc Regulatory News (TST)

Share Price Information for Touchstar Plc (TST)

Share Price is delayed by 15 minutes
Get Live Data
77.00    2.00 (2.67%)
Bid:
74.00
Ask:
80.00
Spread: 6.00 (8.108%)
Market Cap: £6.10m
TST Live PriceLast checked at - London Stock Exchange

Intraday Touchstar Plc Share Chart

AGM & Trading Update

21 May 2008 08:07

RNS Number : 9407U
Belgravium Technologies PLC
21 May 2008
 



For Immediate Release

21 May 2008

Belgravium Technologies plc

(BVM:AIM)

AGM and Trading Update

At the Annual General Meeting of Belgravium Technologies plc ("Belgravium" or the "Company"), to be held at the offices of Buchanan Communications at 10.30 today, Chairman, John Kembery, will make the following statement:

"Belgravium delivered a solid set of results for 2007, showing an 11% increase in both profit before tax and earnings per share. Belgravium Ltd performed well and major benefits were derived from the successful integration of TouchStar and NovoIVC.

The company is not immune from wider global economic conditions and recent trading in 2008 has seen a slow down in the number of forward order contracts secured. The longer term pipeline of new projects remains very healthy although short-term visibility on when they might come to fruition, is poor. Although the company benefits from a good degree of repeat business, the lack of new contracts will produce a first half result substantially below expectations.

The Directors are committed to a growth strategy and are proposing no change in this policy. We continue to examine acquisition opportunities and have developed a new high specification product which will be launched shortly. Pre-production samples have received general acclaim and we have already gained agreement covering forward orders for 5000 units.

Customers have a real need for Belgravium systems and the efficiency savings they bring and cannot postpone purchases indefinitely. Almost no contracts have been lost to competitors but, as the purchasing decision is regarded as a capital project, it is subject to the severe financial constraints prevalent in the current market. Our analysis leads us to believe that this situation will be remedied later in the year and those sales and profits will be restored to the expected annual running rate by the final quarter.

Whilst Belgravium, like all Companies, is experiencing the effects of current markets, we are convinced and comforted that this is not driven by a permanent change in our specific industry and that the Company is positioned strongly to address demand once markets recover."

For further information please contact:

Buchanan Communications Ltd
Suzanne Brocks
020 7466 5000
 
 
Belgravium Technologies Plc
John Kembery
Mob: 07770 731021
 
 
WH Ireland
Gary Marshall
0113 394 6610
 
 
KPMG Corporate Finance
(Nominated Adviser)
Christian Mayo
0161 246 4000

 

 

 

 

 

KPMG Corporate Finance, a division of KPMG LLP which is authorized and regulated by the Financial Services Authority for investment business activities, is acting for the Company as nominated adviser in relation to the matters set out in this announcement and is not acting for any other person in relation to these matters. KPMG Corporate Finance will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQFLBLVEBEBBD
Date   Source Headline
7th May 20267:00 amRNSResults for the year ended 31 December 2025
24th Mar 202612:00 pmRNSDirector/PDMR Shareholding
5th Mar 20263:30 pmRNSDirector/PDMR Shareholding
25th Feb 20269:49 amRNSDirector/PDMR Shareholding
10th Feb 20263:04 pmRNSDirector/PDMR Shareholding
9th Feb 202612:03 pmRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSDirector/PDMR Shareholding
12th Jan 202610:58 amRNSHolding(s) in Company
16th Dec 20257:00 amRNSTrading Update
4th Nov 202512:12 pmRNSHolding(s) in Company
29th Oct 20253:59 pmRNSHolding(s) in Company
29th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 202510:10 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSInterim Results
8th Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202511:09 amRNSTransaction in Own Shares & TVR
26th Aug 20258:51 amRNSTransaction in Own Shares
18th Aug 202510:07 amRNSTransaction in Own Shares
11th Aug 20258:16 amRNSTransaction in Own Shares
4th Aug 20258:53 amRNSTransaction in Own Shares
28th Jul 20252:00 pmRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 202512:28 pmRNSResults of AGM, Business Update & Share Buyback
24th Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
6th May 20259:22 amRNSShare Buyback Programme
29th Apr 20257:00 amRNSFinal Results
17th Apr 20257:00 amRNSNotice of Results & Investor Meet Company
18th Mar 20257:00 amRNSDirectorate Change and Strategic Update
17th Feb 20257:00 amRNSTrading Update & Conclusion of Strategic Review
12th Dec 20244:57 pmRNSForm 8.3 - Touchstar PLC
29th Oct 20247:00 amRNSTrading Update
21st Oct 20247:46 amRNSForm 8.3 - Touchstar plc
16th Oct 20242:35 pmRNSForm 8.3 - Touchstar plc
9th Oct 20245:11 pmRNSForm 8.3 - Touchstar PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.